StockPriceToday
Copart Inc (CPRT)
About Copart Inc
Copart Inc. provides online auctions and vehicle remarketing services for automotive dealers, rental car companies, banks, and insurance companies worldwide. The company's technology-enabled auction platform has made CPRT stock price sensitive to vehicle accident rates, used car demand, and automotive industry trends.
Copart's online auction platform enables buyers worldwide to bid on damaged, aged, and low-value vehicles through internet-based auctions. The company's technology solutions help sellers maximize vehicle values while providing buyers with convenient access to inventory.
The company's network of storage facilities and transportation services provides comprehensive vehicle processing and logistics solutions. Copart's expansion into international markets and additional vehicle categories demonstrates its growth strategy, affecting CPRT stock price performance.
Copart's asset-light business model and technology advantages have enabled consistent profitability and market share growth. The company's ability to leverage technology innovation while expanding globally remains important for its continued success in the vehicle remarketing industry.
CPRT Stock 12 Month Chart
Latest News for CPRT
Copart, Inc. (CPRT) closed the most recent trading day at $27.61, moving -2.4% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 1.01%. Elsewhere, the ...
In the latest close session, Copart, Inc. (CPRT) was down 2.88% at $27.52. This change lagged the S&P 500's 0.42% gain on the day. Elsewhere, the Dow saw an upswing of 0.29%, while the tech-heavy ...
Shares of Copart Inc. CPRT slipped 2.57% to $29.24 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.72% to 7,537.43 and the ...
Other Popular Stocks
Sportradar Group AG (SRAD) is a leading global sports technology company providing data, content, and technology solutions to sports leagues, betting operators, media companies,...
Gilead Sciences Inc. researches, develops, and commercializes medicines in areas of unmet medical need worldwide, with focus on antiviral products.
Generation Bio Co. (GBIO) is a biotechnology company developing non-viral gene therapies for rare and prevalent diseases using proprietary delivery technologies.